Sanofi Oncology, a division of global healthcare company Sanofi, focuses on developing and delivering innovative treatments for various types of cancer. With a rich heritage in oncology, Sanofi Oncology leverages its extensive knowledge base to research and treat cancer from multiple angles, addressing diverse patient needs and disease stages. The company's portfolio includes therapies for rare diseases, immunology, and cardiovascular conditions, among others. Sanofi's commitment to patients drives its strategy to create long-term value through innovative treatments, from research and development to manufacturing and marketing.
Business Partner Rare Disease Cluster, Global MSAT
Cris De Luca
Partner, Digital Investments, Sanofi Ventures
Lydia Mikhaylyants
Associate Director, Global Market Access-Strategic Pricing, Rare Disease and Rare Blood Disorders
John O'Malley
Principal Clinical Research Director and Global Clinical Lead, Amlitelimab
Alexander Sinclair-Wilson Ph.D
Associate Director of Investments
Laia Crespo-Martin Ph.D
Partner
Past deals in Central Africa
Kasha
Private Equity Round in 2024
Kasha is a Rwanda-based e-commerce company, established in 2016, that operates in Rwanda and Kenya. It specializes in distributing a wide range of personal care and health products tailored to women, including menstrual care, sexual health items, pharmaceuticals, and mom and baby care products. Kasha's online platform ensures accessibility to these products in both urban and rural areas, promoting women's health and well-being at various life stages.
Dawa Mkononi
Seed Round in 2024
We are a pharmaceutical company dedicated to improving access to medicine in East & Central Africa. We mainly focus on data-driven healthcare solutions that increase access and quality of information as well as facilitate safe, effective, and sustainable pharmaceutical supply chains across the industry. Our mission is to increase access to high-quality medicines, services, and information via technology solutions that improve affordability, health outcomes, and ease of use.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.